Manager TitleAgeSince
Corporate Secretary - 12/06/2019
Human Resources Officer 53 10/12/2015
Director TitleAgeSince
Director/Board Member 69 09/02/2022
Chairman 72 29/03/2017
Director/Board Member 74 08/04/2010
Date Insider Type Main position Quantity % Market Cap. Importance
27/04/21 OtherCompany 1,452,000 0.3656%
26/04/21 OtherCompany 748,000 0.1883%
21/04/21 OtherCompany 1,526,000 0.3842%
Change 5-day change 1-year change 3-year change Capi.($)
+40.94%+1.70% - - 96.5M
+2.83%+4.40%+60.84%+126.60% 1,133B
+3.81%+5.66%+38.70%+76.77% 621B
+0.14%+0.63%+24.71%+97.05% 503B
+0.03%+5.72%+39.64%+64.06% 379B
-1.76%+1.41%+68.06%+42.47% 370B
+1.58%+5.07%+23.26%+51.98% 292B
+2.90%+5.53%+4.06%+24.45% 262B
+2.04%+3.05%+51.12%+63.80% 237B
+2.36%-0.11%+29.42%+102.67% 190B
Average +5.56%+3.22%+37.76%+72.21% 443.11B
Weighted average by Cap. +1.97%+3.73%+42.92%+84.30%
Logo Lansen Pharmaceutical Holdings Limited
Lansen Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company operates through three segments. Specialty Pharmaceuticals segment is engaged in the development, production and sales of specialty pharmaceuticals mainly used in the fields of rheumatology and dermatology. Its main specialty pharmaceutical products include pafulin, leflunomide tablets and mycophenolate mofetil dispersible tablets. Plant Extract and Healthcare Products segment is engaged in the development, production and sales of Chinese medicine extracts and healthcare products. Other Pharmaceuticals segment is engaged in businesses related to other pharmaceuticals.
Employees
652